Human CD34+/Thy-1 +/Lin-hematopoietic cells purified from bone marrow (BM) or mobilized peripheral blood (MPB) are highly enriched for pluripotent stem cells. Ex vivo expansion of this population is proposed as a means of providing accelerated short-term, as well as long-term, engraftment after myeloablative therapy. Here we demonstrate that primitive quiescent cells are retained in bulk expansion cultures of CD34+/Thy-l+/Lin-cells and that the cell production capaci t y of the expanded cell product can largely be attributed to cells exhibiting quiescent behavior during culture. CD34+/ Thy-l+/Lin-cells from adult BM or MPB were labeled with the fluorescent membrane dye PKH26, followed by in vitro culture of 104 cells on a murine stromal layer in the presence of interleukin (IL)-3, IL-6, c-kit ligand (KL), and leukemia inhibitory factor (LIF). With each subsequent cell division, PKH26 fluorescence is reduced by roughly half, which allows tracking of the number of cell divisions. Progenitor cells present after a 2-week expansion period were sorted into CD34+/Lin-/dyeMaM and CD34'/Lin-/dyed'" fractions and then cultured in a &week single-cell proliferation assay to characterize the proliferative capacity of each group. Hematopoietic cell transfusion products for myeloablated patients must provide both short-term and long-term engraftment. Short-term engraftment is generally defined as the restoration of clinically relevant levels of circulating neutrophils and platelets, while long-term engraftment requires that a pool of stem cells be established in vivo that provides life-long function of the hematopoietic organ. With the presumption that better engraftment can be achieved using a higher cell dose, protocols have been designed to expand hematopoietic cell numbers in vitro. A variety of cell compositions have been proposed as suitable materials from which to expand hematopoietic stem cells and progenitors. These pre-expansion compositions include whole or mononuclear hematopoietic cell mixture^,^.' selected CD34 positive progenitors," or highly purified primitive nine percent of progenitors remaining dyebwht after bulk culture (four or fewer cell divisions) were observed to proliferate in single cell culture, and produced an average of 1,780 cells per plated cell. In contrast, only 26% of dyedm (more than four divisions) progenitors were observed to proliferate and displayed a lower average prolirative capacity of 225 cells per plated cell. Similar behaviors were observed after a second consecutive cycle of bulk culture, indicating that quiescent cells with high proliferative capacity existed in culture for at least 4 weeks. Single CD34+/Lin-/dyebdgM progenitors purified from bulk cultures were observed to produce as many as 1,000 CD34 positive progeny during single cell culture, and these progeny included multilineage colony forming cells. These data demonstrate that among CD34 positive cells recovered after in vitro bulk culture, a higher proliferative capacity correlated with quiescent behavior. The described culture method provides quantitation of the cell producing capacity of individual cells in hematopoietic cell mixtures and may prove useful for predicting engrafting potential in products intended for cellular therapy.
Human CD34+/Thy-1 +/Lin-hematopoietic cells purified from bone marrow (BM) or mobilized peripheral blood (MPB) are highly enriched for pluripotent stem cells. Ex vivo expansion of this population is proposed as a means of providing accelerated short-term, as well as long-term, engraftment after myeloablative therapy. Here we demonstrate that primitive quiescent cells are retained in bulk expansion cultures of CD34+/Thy-l+/Lin-cells and that the cell production capaci t y of the expanded cell product can largely be attributed to cells exhibiting quiescent behavior during culture. CD34+/ Thy-l+/Lin-cells from adult BM or MPB were labeled with the fluorescent membrane dye PKH26, followed by in vitro culture of 104 cells on a murine stromal layer in the presence of interleukin (IL)-3, IL-6, c-kit ligand (KL), and leukemia inhibitory factor (LIF). With each subsequent cell division, PKH26 fluorescence is reduced by roughly half, which allows tracking of the number of cell divisions. Progenitor cells present after a 2-week expansion period were sorted into CD34+/Lin-/dyeMaM and CD34'/Lin-/dyed'" fractions and then cultured in a &week single-cell proliferation assay to characterize the proliferative capacity of each group. Fifty-HE PAST SEVERAL YEARS have seen increasing efforts to develop methods of in vitro manipulation of hematopoietic cell mixtures for the purpose of increasing their therapeutic value as transfusion products. Several approaches toward increasing the therapeutic value of hematopoietic transplant materials are under investigation. First, efforts have been made to expand the number of hematopoietic cells of a critically needed type, such as megakaryocyte'.' and neutrophil progenitor^,^ or multipotent stem cells.435 These manipulations may result in quicker, more sustained engraftment, as well as less costly and invasive harvesting procedures. Conversely, removal of potentially harmful cells, such as tumor cells that could result in relapse of disease, or alloreactive T cells causing graft-versus-host disease (GVHD), has been performed by various means such as culturing: immunoselection, and treatment with cytotoxic drugs. Other in vitro manipulations are aimed at altering the function of hematopoietic cells, such as transduction with therapeutic genes' or inducing immune activation and expansion of T-cell clones toward specific tumor antigens. ' Hematopoietic cell transfusion products for myeloablated patients must provide both short-term and long-term engraftment. Short-term engraftment is generally defined as the restoration of clinically relevant levels of circulating neutrophils and platelets, while long-term engraftment requires that a pool of stem cells be established in vivo that provides life-long function of the hematopoietic organ. With the presumption that better engraftment can be achieved using a higher cell dose, protocols have been designed to expand hematopoietic cell numbers in vitro. A variety of cell compositions have been proposed as suitable materials from which to expand hematopoietic stem cells and progenitors. These pre-expansion compositions include whole or mononuclear hematopoietic cell mixture^,^.' selected CD34 positive progenitors," or highly purified primitive nine percent of progenitors remaining dyebwht after bulk culture (four or fewer cell divisions) were observed to proliferate in single cell culture, and produced an average of 1, 780 cells per plated cell. In contrast, only 26% of dyedm (more than four divisions) progenitors were observed to proliferate and displayed a lower average prolirative capacity of 225 cells per plated cell. Similar behaviors were observed after a second consecutive cycle of bulk culture, indicating that quiescent cells with high proliferative capacity existed in culture for at least 4 weeks. Single CD34+/Lin-/dyebdgM progenitors purified from bulk cultures were observed to produce as many as 1,000 CD34 positive progeny during single cell culture, and these progeny included multilineage colony forming cells. These data demonstrate that among CD34 positive cells recovered after in vitro bulk culture, a higher proliferative capacity correlated with quiescent behavior. The described culture method provides quantitation of the cell producing capacity of individual cells in hematopoietic cell mixtures and may prove useful for predicting engrafting potential in products intended for cellular therapy.
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Expansion is supported with mixtures of various hematopoietic cytokines and in some cases bone marrow (BM) stromal layers and results in a mixture of primitive and more differentiated cells. This ex vivo culture process is routinely referred to as stem cell or progenitor expansion, without a requirement that stem cells or primitive progenitor subsets increase in number. It remains unresolved whether cells are permanently lost from the stem cell compartment during ex vivo culture, resulting in reduction of long-term engraftment potential. Although long-term engraftment with ex vivo expanded hematopoietic cells has been demonstrated in durable engraftment in man after cell number expansion or other in vitro manipulations remains to be adequately tested.
These studies were oriented towards developing a short and reproducible in vitro assay that could predict the potential clinical benefit of stem cells expanded in vitro. Currently available in vivo assays using animal models have provided valuable information about engraftment potential of a cell p~pulation,'".'~ however, they are by nature not well suited for quantitative potency assessment. In vitro assays that detect long-term culture initiating cells (LTCIC) and cobblestone area forming cells (CAFC) typically produce a readout 546 YOUNG ET AL in 5 to 8 week^.^.'^ We previously reported the development of an in vitro assay system for single cells that provides quantitative information about the potential of individual progenitors within a hematopoietic population.'* Here, we have combined quantitative analysis of single cells with tracking of cell division number during expansion culture. This allowed the phenotype and number of divisions of a cell during expansion culture to be correlated with its subsequent behavior. We report here that the cells with the highest proliferative capacity remained relatively quiescent during in vitro culture.
This method can be used to discover conditions that result in the greatest expansion and least differentiation of hematopoietic progenitors possible. In addition, it can be used to investigate differences between hematopoietic tissue sources such as BM, MPB, and cord blood and define their suitability for various clinical applications.
MATERIALS AND METHODS

Antibodies
TuK3 (anti-CD34) and GM201 (antihuman Thy-l) were used to purify primitive progenitors by flow cytometry. FLOPC 21 mouse IgG3 (Sigma, St Louis, MO) and purified mouse IgGl [Becton Dickinson, Mountain View, CA] were used as controls for CD34 and Thy-l staining, respectively. Goat antimouse IgG3 conjugated to sulfa-rhodamine (SR) was purchased from Southern Biotech Associates (Birmingham, AL). Goat antimouse IgGl conjugated to phycoerythrin (PE) was purchased from Caltag (So San Francisco, CA). For some experiments TuK3 and FLOW 21 directly conjugated to SR (prepared at SyStemix Inc) were used. Fluorescein isothiocyanate (FITC)-conjugated lineage antibodies Leu-Sb (anti-CDZ), Leu-M3 (anti-CD14), Leu-M1 (anti-CDlS), Leu-lla (anti-CD16), Leu-l2 (anti-CD19), FITC conjugated mouse IgGl and IgG2a, PE conjugated HPCA2 (anti-CD34), Leu M9 (anti-CD33), and mouse IgGl were purchased from Becton Dickinson. FITC-conjugated antibody D2.10 (antiglycophorin) was purchased from AMAC (Westbrook, ME). Mouse IgM was purchased from Sigma. Human gamma globulin (Gamimune), was purchased from Miles Inc (Elkhart, IN). (JRH Biosciences, Lenexa, KS), 10% fetal bovine serum (FBS) (Gemini Bioproducts, Calabasas, CA), 50 U/mL penicillin, and 50 pg/ml streptomycin (JRH Biosciences)]. CD34 positive selection was performed by the method of Sutherland." The glycoprotease from Pasteurella Haemolytica used for the bead release step in this procedure has been shown not to affect subsequent ex vivo expansion of progenitors."
Enrichment of Progenitor Cells
A frozen aliquot containing 2 X lo6 CD34' cells from cadaveric BM was kindly provided by Dr S. Kessler (SyStemix Inc). Selection of cadaveric CD34+ cells was performed using biotinylated anti-CD34 antibody and antibiotin-coated Dynal magnetic beads with biotin competition release (S. Kessler, manuscript in preparation).
MPB samples from multiple myeloma (MM) patients were obtained after informed consent from the University of Arkansas Medical Center (Little Rock, AR). MM patients were mobilized with cyclophosphamide and granulocyte-macrophage colony-stimulating factor (GM-CSF). MPB samples were fractionated using a JE5.0 Beckman counterfIow elutriator equipped with a Sanderson chamber (Beckman Instruments Inc, Fullerton, CA), and the fractions enriched for CD34+ cells were pooled as previously described.*' CD34' cells were further purified using the method of Sutherland" described above for fresh BM aspirates.
Fluorescent Labeling and Flow Cytometry of Primary Tissue
CD34' enriched hematopoietic cells were adjusted to a concentration of 2 X 106/mL in staining medium [RPMI 1640 without phenol red, 2% FBS, and 10 mmol/L HEPES (Sigma)] and labeled using a three-step procedure performed on ice. The incubation time for each staining step was 20 minutes followed by a wash with 3 mL of staining medium.
Heat inactivated human gamma globulin (Gamimune) was added to the cell suspension at a concentration of 1 mg/mL to block Fc receptor binding sites.
Step 1: Cells were incubated with anti-CD34 (7 pg/mL) and anti-Thy-l (IO pg/mL) or irrelevant mouse IgG3 (7 pg/mL) and IgGl (10 pg/mL) control antibodies.
Step 2: Cells were incubated with goat antimouse IgG3-SR and goat antimouse IgGI-PE. (In some cases, cells were stained using CD34 antibody directly conjugated to SR and incubation with goat antimouse IgG3-SR was omitted).
Step 3: Cells were resuspended in staining medium containing 20 pg/mL mouse IgGl to block any unbound goat antimouse IgGl from the previous step, then incubated with a mixture of FITCconjugated antibodies directed against a panel of lineage markers. The mixture included anti-CD2, anti-CD14, anti-CD15, anti-CDl6, anti-CD19, and antiglycophorin A. FITC-conjugated mouse IgGl, IgGZa, and IgM were used as controls for the lineage panel. Following antibody staining, cells were resuspended at a concentration of lo6 cells/nL in staining medium containing 1 pglmL propidium iodide (PI) (Molecular Probes Inc. Eugene OR). Fluorescently stained cells were analyzed and sorted on a FACStar Plus cell sorter (Becton Dickinson). Dead cells (PI positive) and lineage positive cells (stained with an intensity above the isotype matched control antibody staining) were excluded from the sort gate. From the live, lineage-negative cells the CD34+/Thy-l+ fraction was sorted.
PKH26 Fluorescent Dye Labeling
Labeling was performed per manufacturer's instructions (Zynaxis Cell Sciences Inc, Malvern, PA) following sorting and before culturing in bulk.
Murine Stromal Cells
Derivation of Sysl. Murine BM adherent cell cultures grown by the method of Whitlock and Witte" were single cell cloned. Each stable, contact inhibited clone was then tested for its ability to support murine B lymphopoiesis and myelopoiesis. Sysl is a clone that consistently showed support. These stromal cells were subsequently shown to support human hematopoiesis, promoting expansion of cells with primitive immunophenotypes and multilineage differentiation ~a p a b i l i t y . '~~~' .~~ Analysis offactorsproduced by Sysl. By RNA polymerase chain reaction (PCR) analysis, Sysl expresses murine interleukin (IL)-2, IL-6, IL-7, M-CSF, LW, KL Flk-2 ligand, transforming growth factor (TGF)-beta, and basic fibroblast growth factor (bFGF). Low levels of IL-1, IL-5, tumor necrosis factor (TNF) alpha, GM-CSF, and G-CSF transcripts were also detected. Protein expression of some of these factors have been confirmed by bioassay. Sysl does not express An equal number of CD34+ cells from each culture was plated in methylcellulose culture and analyzed for LTCIC content by the method of Sutherland." The data are shown in Table 1 .
Bulk Culture
Approximately 1 X lo3 Sysl mouse stromal cells were seeded into 24-well plates (Coming, Coming, NY) in 1 mL stromal culture medium [RPMI 1640, 5% FBS, m o w 2-mercaptoethanol (2-ME) (Sigma), 4 mmoVL glutamine, 50 U/mL penicillin, and 50 pg/ mL streptomycin]. Stromal cells were allowed to form a confluent monolayer by culturing for 4 to 7 days. At confluence monolayers were irradiated (1,000 rads from a cesium source) to prevent overgrowth. Immediately before seeding with hematopoietic cells, the medium was removed and replaced with stem cell culture medium
100 mmoVL Na pyruvate (JRH Biosciences), 4 mmolft glutamine, 50 U/mL penicillin, 50 pg/mL streptomycin, 50 pg/mL 30% iron saturated human transferrin (Sigma), 10 ng/mL recombinant human (rh)IL-3 (Genzyme, Cambridge, MA), 10 ng/mL rhIL-6 (Sandoz, Basel, Switzerland), 50 ng/mL rhKL,, and 10 ng/mL rhLIF (Tago/Biosource, Camarillo. CA)]. Ten thousand PKH26 dye labeled CD34+Rhy-l+/Lincells were seeded onto the stromal layers in a final volume of I mL. Cocultures were maintained for 2 weeks in a 37°C humidified incubator containing 5% CO2 and 10% 0, and fed weekly by replacement of half of the medium with fresh medium. In some experiments, parallel cultures were established under the same conditions, except without the Sysl stromal layer.
After a 2-week culture period, cells were harvested and stained as described above for the primary sort, except that Thy-1-PE staining was omitted. CD34'Lin-cells were sorted into two groups, dyebnght and dyedi", using the following strategy. The PKH26 dye fluorescence intensity of the starting population (following dye labeling and before bulk culture) was approximately 4,000. Following culture, CD34+/Lin-cells with a dye intensity of greater than 250 were classified as dyebnph' and those less than 250 as dyedi". These two populations were each deposited at one cell/well into Terasaki plates (Robbins Scientific, Sunnyvale, CA) using an automated cell deposition unit (ACDU) (Becton Dickinson). The position of the cell stream was preset by depositing a fluorescent bead into each well of a test plate before cell sorting. The accuracy of single bead deposition was greater than 99% as assessed by microscopic observation. Fluorescent images were captured (see below) of each Terasaki well on day 0 (after sorting) to determine the number of hematopoietic cells each well received as detected by their PKH26 dye label. Only wells receiving one cell were considered in analysis.
Single Cell Culture
Terasaki plates used for single cell deposition were preseeded with Sysl mouse stromal cells at approximately 50 cells per well in 20 pL of stromal cell culture medium and irradiated at confluence as described above for 24-well cultures. Immediately before seeding of hematopoietic cells, 10 pL of medium was removed and replaced with 10 pL SCCM. Following single cell deposition, cocultures were maintained for 4 weeks with weekly replacement of half of the culture medium.
lmaainn and Cell Number Quantitation
Images of Terasaki well single cell cultures were digitized and stored three times per week. Magnification was adjusted such that the entire well was visible in each image. An inverted Nikon Diaphot microscope and Hamamatsu C2400 Newvicon CCD camera were used for image acquisition. An Image-l system and Compaq 66-MHz 486 computer were used for digitizing hardware and image analysis software (Universal Imaging, Philadelphia, PA). A Panasonic LF-7010 rewritable optical disk drive was used for image storage.
Cell numbers were determined from the image series by direct counting (< 100 cells); or by estimating the proportion of the well filled (>l00 cells). Average cell number in confluent wells was determined by hemacytometer counting (data not shown).
Phenotypic Analysis of Subconjtuent and Conjtuenz Terasaki Wells
Single cells which grew to fill an entire Terasaki well with blast cells were individually analyzed by flow cytometry for the percentage 
IgG1 -PE
Clonogenic Assay
Clonogenic cells were enumerated as described previously.z6 Briefly, the contents of individual wells were removed by gentle pipetting and plated directly into 0.25 mL cultures containing IMDM supplemented with 30% FCS, 5 X m o m 2ME, 1.1% methycellulose (Fisher Scientific, Pittsburg, PA), 10 ng/mL E-3, 2 ng/mL GM-CSF, 100 ng/mL KL, and 2 U/mL erythropoietin (EPO). Colony number and type were microscopically scored after 2 weeks of incubation at 37°C in a humidified atmosphere of 5% COz and 10% 02.
RESULTS
Growth Potential of Single Progenitors PuriJied From Expansion Cultures
CD34+/Thy-l+Lin-hematopoietic cells from or MPB2'227 are highly enriched for pluripotent stem cells. The CD34+/Thy-l+/Lin-population was purified from CD34+ enriched normal adult BM and MPB patient tissues using the gating strategy shown in Fig 1. This fraction represented 20% to 30% of the total CD34+ enriched population from the four tissues analyzed. To track division history during bulk culture expansion, the CD34+/Thy-l+iLin-cells were labeled following flow cytometric purification with the fluorescent membrane dye PKH26. This reagent has been used previously to study division history of hematopoietic cells in culture.''.28 Dye intensity is reduced by roughly one half with each cell division. The dye had no effect on total cell proliferation or expansion of a CD34+Lin-population in bulk culture or on plating efficiency and total proliferation in single cell culture. This was determined by comparison with nondye labeled samples from the same tissues (data not shown). Loss of dye by diffusion was minimal over the 4-week culture period (a half-life of 100 days was reported by the manufacturer).
PKH26 dye labeled CD34+/Thy-l+/Lin-cells were cultured at lo4 cells/mL on the Sysl murine stromal monolayer in the presence of the hematopoietic cytokines L-3, L-6, KL, and LIF. These conditions were chosen to maximize primitive cell cycling and blast cell production. It may have been possible to produce greater total numbers of mature cells if factors such as GM-CSF, G-CSF, or EPO had been used. Sysl stroma was chosen because we had previously compared Sysl with primary human stroma established under Dexter culture conditions for ability to support human hematopoiesis. Cord blood CD34+ progenitor cells cultured for 5 weeks on the two different stromas were analyzed for expansion of total cell numbers, multilineage differentiation, production of CD34+ cells, and maintenance of LTCIC (Table 1) . Sysl outperformed primary human stroma for each of these measurements.
For
The experimental strategy used to determine the proliferative capacity of progenitors produced during ex vivo culture is depicted in Fig 2A. After a 2-week expansion period, total cell numbers had increased 20 to 120-fold. The cultures were harvested, fluorescently stained for CD34 and lineage antigens, and analyzed by flow cytometry for expression of these antigens relative to PKH26 dye intensity. Figure 3 shows histograms of the PKH26 dye intensity of the starting population relative to the expanded cell population after 2 weeks in culture. The vast majority of cells had undergone more than four divisions. As shown in Fig 4, cultured cells that remained primitive (expressed CD34 but not lineage antigens) were segregated into two groups based on the mean dye intensity of the starting population: those that had divided (reduced their dye intensity by half) four or fewer times (CD34+/Lin-/dyebnght), and those that had divided more than four times (CD34+/Lin-/dyedim). The percentage of CD34+/Lin-cells in the expanded populations ranged from 5% to 15%. As can be seen in Fig 4, the CD34-population of the cultured cells was entirely dyedim. This population consistantly displayed a very low proliferative capacity (an average cell production of three cells per cell) when tested in the single cell proliferation assay (see Table  3 ).
In some experiments, stroma free cultures were performed in parallel with the Sysl cocultures. Similar numbers of total cells were produced in the two types of cultures, however, the percentage of CD34 positive cells produced was consistently lower in stomal free cultures by up to sevenfold. This manifested as a greater degree of loss of CD34 expression as cells underwent division (became dyedi") in the stroma free cultures.
A single cell proliferation assay described previously18 was used to compare the proliferative capacity of the CD34+/ + Lin-/dyebrigh' and CD34+/Lin-/dyedi"' populations. Growth of each cell was tracked by acquiring images of each culture well at 2 to 3-day intervals for 4 weeks. Imaging allowed precise quantitation of cell numbers for generation of growth curves, quantitation of total cell production, and documentation of growth patterns. Figure 5 shows a representative image series of a well that grew to confluence with blast cells. At early time points in culture, fluorescent images were taken because PKH26 dye labeling allowed easy detection of cells on or under the stromal layer. However, later as the dye was diluted due to extensive cell division, bright field images were taken. Table 2 shows the plating efficiencies of single CD34+/ Lin-/dyebrigh' and dyedim cells following bulk culture of each of the four tissues. Plating efficiency is defined as the percentage of single cells that divided one or more times. The peak of proliferation for adult cells following single cell plating was observed to occur between 2 and 3 weeks, therefore, plating efficiency was scored during this time period. For each of the tissues analyzed; a cryopreserved cadaveric BM, a fresh adult BM, and two patient MPB samples; plating efficiencies of the dyebright populations exceeded those of the dyedim populations. The average for the four tissues was 59% (dyebrig") and 26% (dyedim). Plating efficiencies of cells harvested from parallel stroma free cultures (adult BM no. 2 and MPB no. 4) were similar to those of cells from cocultures (Table 2) .
To compare total cell production from each single cell plated, the peak cell number achieved was determined from each image series (Fig 6) . The overall average production for the four tissues was 1,780 cells produced per input cell (cellskell) for the CD34+/Lin-/dyengh' fraction, and 225 cells/cell for CD34+/Lin-/dyedi"' fraction. Cells from adult BM no. 2 and MPB no. 4 expanded in stromal free culture displayed similar proliferative capacities to the cells from parallel cocultures (Fig 6) . This indicates that growth on the murine stroma did not influence the subsequent behavior of the CD34+/Lin-/dyeb"gh' and dyedim cell subsets. It appeared to only influence the number of cells from each of these subsets that could be obtained from the bulk cultures.
Highly Proliferative Quiescent Cells Are Maintained Through 4 Weeks of Bulk Culture
Two of the tissues, (BM no. 2 and MPB no. 4) were subjected to two consecutive 2-week bulk culture cycles, each followed by single cell plating. Secondary bulk cultures were initiated with CD34+/Lin-/dyebnght cells purified from the primary bulk cultures. The CD34+/Lin-/dyedim populations were also recultured, however, they produced too few CD34+/Lin-cells to be subsequently tested for single cell proliferation. Figure 7 shows that although the average proliferation of CD34+/Lin-/dyehngh' cells was lower after secondary bulk culture than after primary bulk culture, (1,920 and 2,970, respectively for tissue no. 2), highly proliferative cells still remained. Table 3 shows the estimated total cell production (tissue no. 2) from the primary 10,000 CD34+/ Thy-l'/Lin-cells after one bulk culture period and after two consecutive bulk culture periods. The total cell production For personal use only. on October 22, 2017 . by guest www.bloodjournal.org From 
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and (F) were obtained using bright field microscopy. Plating efficiency was scored at 2.5 weeks after plating in single cell culture, and is defined as the number of cells out of the total number plated that divided one or more times. Plating efficiencies of single CD34+/Lin-cells from both Sysl stroma supported and stroma free bulk cultures are shown.
potential from the original 10,000 cells was 36,750,000 cells or approximately 3,670 cells per input cell.
Single Cells Remaining Quiescent During Bulk Culture Produced Primitive Multipotential Progeny
As detailed in Fig 6, 33 of 198 BM cells and 8 of 207 MPB cells from the CD34'/Lin-/dyebright populations grew to at least 80% confluence (approximately 8, OOO blast cells). CD34+/Lin-/dyedi" cells did not proliferate to this level of confluence or maintain blast morphology except in rare cases. Therefore, subsequent analysis was restricted to dyehright cells. To determine the progenitor content of the morphologically primitive progeny of single CD34'/Lin-/ dyehrigh' cells, we used the strategy depicted in Fig 2B. Wells from tissue no. I that were 80% confluent or greater with blast cells were individually analyzed for expansion of progenitors (CD34 positive cells) by flow cytometry. CD34 positive cells could be detected in some of these wells and not others (Fig 8, top panels) . In some cases, several subconfluent (30% to 80%) blast-containing wells were pooled for analysis. Figure 8 (bottom panels) shows analysis of a pool of six subconfluent wells from tissue no. 2. An approximate 1,000-fold expansion of CD34 positive cells was observed from the progeny of these six initiating cells. For personal use only. 
Subconfluent and confluent wells grown from single
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This evidence supports a maturation model for in vitro hematopoietic cell expansion as opposed to a stochastic exit from the stem cell compartment. These findings support earlier models proposed to explain tissue regeneration in vivo. In 1965, Kay proposed an "asynchronous-logarithmic'' model, which predicts that each cell division results in aging, and delineates how a maximum number of mature cells can be produced with a minimum number of divisions of a stem cell
In 1979, Rosendaal et a130 tested a "generationage" model for hematopoiesis using serial transplantation and spleen colony generation in mice, based on the earlier work of Till and McC~llough.~' Both models propose that stem cells age as they divide within the stem cell pool, each division resulting in decreased proliferative capacity. After a limited number of divisions, cells leave the stem cell compartment and terminal differentiation is inevitable. Aging within the stem cell compartment may result in differential abilities to respond to inhibitors and stimulators of proliferation,28.32-34 which in turn, influences the probability that a stem cell will enter cell cycle.
The aging phenomenon has been demonstrated to occur in ex vivo culture systems as well as in vivo, as repeated passaging of hematopoietic progenitors in culture eventually leads to terminal differentiati~n.'~.~~.~~ Telomere shortening, a phenomenon associated with aging, has also been shown to occur during culture. 34 The heterogeneity of behaviors in culture that we observed previously among primitive hema- CD34+/Lin-/dyekgh' cells (tissue no. 2) were analyzed for colony forming progeny by plating the entire contents of individual wells in methylcellulose culture. A portion of the wells analyzed contained multipotent and myeloid colony forming cells among their progeny (Table 4 ). These data indicate that single CD34+/Lin-cells that showed quiescent behavior during expansion culture can produce primitive progeny with extensive expansion capability.
DISCUSSION
Our results indicate that the most highly proliferative and multipotential cells recovered after bulk culture expansion with cytokines were those that demonstrated quiescent behavior. Progressive maturation and loss of cell production capacity appeared to be a consequence of cell division under the culture conditions used here, suggesting that stem cells may have a maximum number of possible divisions in vitro. topoietic cells with the same immunophenotype is consistent with aging within the stem cell compartment." No culture conditions have yet been identified that allow indefinite expansion of stem cell numbers without differentiation. By comparing parallel cultures grown without a stromal support layer and in coculture with Sysl, we observed that the stromal layer increased the number of cells that underwent division, but remained CD34 positive by as much as sevenfold. However, CD34+/Lin-cells harvested from the two culture types displayed similar proliferative capacities when subsequently analyzed as single cells. These results indicate that while differentiation may inevitably occur, conditions can be found that maximize a cell's inherent proliferative capacity. Sysl stroma outperformed primary human stroma for expansion of total cell numbers, CD34+ cell production, support of B lymphopoiesis, and maintenance of LTCIC numbers. Murine stromal lines with similar properties to Sysl have been described, for example, the MS-5
The mechanisms of support by Sysl are not fully understood and have been a subject of ongoing study. However, human hematopoietic progenitors plated on Sysl without the addition of exogenous human cytokines show poor growth. In addition, culture supernatant harvested from Sysl does not augment the growth of progenitors in stroma free culture (unpublished observations). Therefore, we believe that the most influential contribution of the Sysl stromal layer is to provide structural niches required for hematopoietic development.
There have been numerous reports of increases in numbers of primitive hematopoietic cells of a particular functional activity or immunophenotype during culture. Some investigators have reported expansion of LTCIC numbers: while others have shown Reports of expansion of LTCIC numbers in culture are encouraging because LTCIC numbers in fresh MPB and cord blood have been shown to be predictive of time to engraftment:' Primitive cord blood progenitors of the immunophenotype CD34+/CD45RA'"/ CD71'"/Thy-l+ were shown to produce 10,000 CD34+ cells per input cell over a 4-week culture period. Cells maintaining a CD34+/Thy-l+ phenotype expanded 30-fold by 2 weeks, but then declined. 41 We showed previously that single fetal CD34hi/Lin-cells can produce up to 360,000 CD34+ progenitors in culture.'* We demonstrate here that single adult CD34'/Thy-l+/Lin-cells can produce up to 1,000 CD34+ progenitors. However, it must be stressed that these observations are not proof of self-renewal in vitro, nor do they refute the aging theories described above, since equivalence of the original progenitors with their primitive progeny has not been proven.
In vitro cultured cells have been shown to provide longterm engraftment in mi~e'~.'~.~' and at least recovery from neutropenia after myeloablation in Therefore, the expansion of primitive hematopoietic progenitors in vitro may have multiple future therapeutic applications. The key concerns in the various therapeutic scenarios are that the transfused cell population can provide both rapid short-term recovery from cytopenia and life-long reconstitution of the hematopoietic system. Thus, apart from the fold expansion in cell number, it is also important to measure the proliferative capacity of the expanded cells. The single cell proliferation assay described here provides the ability to measure the maximum cell production per input cell. Our finding is that 87% of the cell production was derived from the dyebri*' CD34+ cells. These data suggest that stem cell quiescent behaviors will have an important impact on the potency of cell products derived from bulk culture of hematopoietic progenitors. It remains to be shown whether enough quiescent stem cells can be maintained in bulk culture to provide long-term patient engraftment. The question also remains as to how applicable in vitro results are to actual in vivo cell performance. Ex vivo expansion protocols that preserve the proliferative capacity of primitive hematopoietic progenitors may contribute to a clinically beneficial cell product.
NOTE ADDED IN REVIEW
In the course of the review process for this manuscript, a paper using a similar approach appeared in the literature." The stated purpose of these investigators, to develop a simple in vitro method for assessment of engraftment potential of hematopoietic tissues, was the same as ours.
These investigators measured LTCIC content of CD34+/ dyebrisht and CD34+/dyedi" cells after culture of PKH2-labeled CD34+ cells from adult BM and cord blood. They observed a decrease in total LTCIC numbers relative to the primary tissue over a 7-day culture period. In contrast, we used total proliferative capacity instead of LTCIC numbers to measure the potential of cells after culture and have observed an increase in potential relative to the primary cells of from 1,500 to 2,500 cells per cell (Fig 7 and Table 3 ). The two measurements (LTCIC and proliferative capacity) may not be directly comparable. However, we used a cytokine cocktail of IL-3, IL-6, KL, and LIF, as well as Sysl stromal cell support layers, in our expansion cultures, while the other investigators used only IL-3 and KL, which may account for differences in potential displayed by the cultured cells. Future clinical studies may help determine whether in vitro proliferative capacity measurements provide a useful correlation with short-term and long-term hematopoietic engraftment.
